The microorganisms in biogas plants do a great job biologically converting CO₂ and hydrogen, which are primary fermentation products, into methane. Biomethane has a great future as an energy source. Scientists at the University of Hohenheim are investigating new ways to produce and use biomethane.
https://biopro-v9-test-bio.xanium.io/en/articles/news/new-technologies-for-using-biogas-as-balancing-energyA pill camera to examine the gastrointestinal tract that can be swallowed without major difficulty, controlled intuitively from the outside and deliver images in real time - why would any doctor or patient say no? To non-experts, it sounds more like science fiction but such a device is actually already in development: since 2019, Tübingen-based Ovesco Endoscopy AG and three partners have been working together on this in a project called nuEndo.
https://biopro-v9-test-gi.xanium.io/en/article/news/magenspiegelung-kamerapilleAll eyes are on vaccines against the coronavirus. The Tübingen-based company CureVac is doing pioneering work in this field, and intends to initiate clinical testing of its lead vaccine candidate in June. At the same time, Curevac is manufacturing the material for this vaccine candidate. But that’s not all: the novel mRNA technology also has the potential to revolutionise the treatment of cancer and metabolic diseases. What makes the method so…
https://biopro-v9-test-gi.xanium.io/en/article/news/curevac-als-pionier-der-mrna-technologie-was-steckt-hinter-dem-neuartigen-covid-19-impfstoffInnovative technologies and bacteria can transform wood residues into sustainable bioplastic packaging. Before bioplastics are broken down into CO2 and water in an environmentally friendly way, they can thus lead lives as products in the cosmetics industry, for example.
https://biopro-v9-test-bio.xanium.io/en/articles/news/bioplastics-make-wood-cycles-more-sustainableThe fight against cancer is a pressing issue. Although technological advances in the treatment, prevention and early detection of cancer have improved over the past few decades, the number of people affected is increasing. Cancer medicine now wants to counteract this by joining forces with other players involved in the field.
https://biopro-v9-test-gi.xanium.io/en/article/news/translation-driver-cancer-medicineYuri, a start-up company founded in 2019 in the Lake Constance area, is aiming high. The company’s mission is to enable microgravity research into the development of materials, new medicines and vaccines, including research opportunities on the International Space Station (ISS). Yuri’s tailor-made solutions are faster and more affordable than previous space research missions.
https://biopro-v9-test-gi.xanium.io/en/article/news/reaching-up-into-weightlessness-a-start-up-enables-commercial-research-experiments-in-spaceNovoCarbo GmbH produces biochar from plant residues such as wood chips, nutshells and manure. Different feedstocks, and the way these materials are processed, create biochars with different properties. This makes biochar suitable for different uses, including as a soil conditioner, in biogas plants or as bedding for stables and cowsheds. The Rhizo-Linse project is currently investigating whether biochar is also suitable as inoculant carrier for…
https://biopro-v9-test-bio.xanium.io/en/articles/news/novocarbo-turns-plant-waste-into-biocharThe SARS-CoV-2 coronavirus uses a spike protein to bind to the ACE2 receptor on the cell surfaces of lung tissue. Additional cofactors are needed to allow the virus genome to penetrate human cells and multiply. Knowing these relationships can help understand the course of the infection and develop counterstrategies. To this end, the Constance-based company Trenzyme has produced a recombinant spike protein to support coronavirus research.
https://biopro-v9-test-gi.xanium.io/en/article/news/the-sars-cov-spike-protein-and-its-receptorHow can scientists turn their know-how into marketable products and services and thereby provide society with real added value? In addition to solid financing, start-up companies need a suitable infrastructure and a dense network of partners for exchanging expertise to help them get off to a good start when it comes to setting up a business. The Heidelberg Technology Park offers company founders in the life sciences exactly these success factors.
https://biopro-v9-test-gi.xanium.io/en/article/news/start-up-support-for-life-sciences-companiesBiomass from forestry and agriculture along with residues from industry and households can contribute to our energy and raw material shift. Sustainable, regenerative biomass-based energy can become part of the energy mix of the future within the framework of a bioeconomy.
https://biopro-v9-test-bio.xanium.io/en/articles/news/Sustainable-bioenergyEvery year, around 11 million people die of sepsis (blood poisoning) caused by microorganisms or microbial residues, known as pyrogens, entering the bloodstream. The smallest amounts can trigger fever. Researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart have developed a pyrogen test that does not require a laboratory and is not tested on animals. It is expected to be placed on the market soon.
https://biopro-v9-test-gi.xanium.io/en/article/news/A-rapid-pyrogen-test-the-human-immune-system-as-modelGiven the challenges faced by modern agriculture, it is vital to raise people’s awareness of how to change their approach to food. The founders of the Stuttgart-based start-up company farmee GmbH see urban agriculture as the key to making this change possible. The company has developed “alphabeet”, an app designed to encourage consumers to produce their own food. After all, only those combining knowledge and practical experience can be expected…
https://biopro-v9-test-bio.xanium.io/en/articles/news/alphabeet-the-green-fingered-smartphonePrime Vector Technologies GmbH (PVT), a start-up company based in Tübingen in southern Germany, uses a modular brick system to develop vaccines against cancer and infectious diseases. The PVT team is currently working flat out to develop a COVID-19 vaccine.
https://biopro-v9-test-gi.xanium.io/en/article/news/mit-einem-impfstoffbaukasten-gegen-covid-19Sensor networks are one of the keys to achieving digitalisation of the bioeconomy. Sensor networks are on the way to becoming important analysis and control instruments for energy-efficient and sustainable material cycles. Dieter Hertweck, Professor of Business Information Systems at Reutlingen University of Applied Sciences, shows what is already possible in digital agriculture and waste recycling and what is feasible for the future.
https://biopro-v9-test-bio.xanium.io/en/articles/news/Sensors-for-the-bioeconomyThe CRISPR-Cas gene-editing technology is one of the most important developments in molecular biology in recent years. It utilises molecular scissors with which nucleic acids can be cut and edited almost arbitrarily. Researchers in Freiburg, Germany have now successfully used the technology for diagnostic purposes. They are currently working intensively on expanding the system to enable it to detect genome sequences of the novel SARS-CoV-2 virus.
https://biopro-v9-test-gi.xanium.io/en/article/news/Diagnostics-with-molecular-scissors-is-this-also-possible-for-on-site-COVID-19-testsThere is currently no cure for multiple sclerosis, the most common neurological autoimmune disease in humans. Biopharmaceuticals that can delay the course of the disease or diminish its effects are often prevented from being fully effective by the blood-brain barrier. A European consortium led by the Fraunhofer IGB, Stuttgart is developing a new technology that can transport an innovative active ingredient directly to the central nervous system.
https://biopro-v9-test-gi.xanium.io/en/article/news/Direct-application-of-biopharmaceuticals-through-the-nose-into-the-brainResearchers around the world are working frantically on the development of a vaccine against the new coronavirus. A project by the Tübingen-based biotechnology company CureVac, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), uses the company’s technology platform for mRNA-based vaccines to accelerate vaccine development, thus contributing to the future prevention of the disease.
https://biopro-v9-test-gi.xanium.io/en/article/news/Waiting-for-a-SARS-CoV-2-vaccineLentils were once considered poor man’s food, but in Germany demand for them has never been greater. And to satisfy this growing demand, more lentils need to be cultivated. This is why the University of Hohenheim is involved in the EIP-AGRI "Rhizo-Linse" project. The aim of the project is to find rhizobia strains that go well with lentil plants to increase yield and improve quality.
https://biopro-v9-test-bio.xanium.io/en/articles/news/University-of-Hohenheim-wants-to-improve-the-conditions-for-lentil-cultivationDecentralised, controllable and stable - renewable energy is an important component in the transition to a bioeconomy without fossil fuels. BIOPRO spoke to PD Dr. Andreas Lemmer from the State Institute of Agricultural Engineering and Bioenergy at the University of Hohenheim and Prof. Dr. Stefan Pelz, scientific director of the Institute for Applied Research and professorat the University of Applied Forest Sciences Rottenburg.
https://biopro-v9-test-bio.xanium.io/en/articles/news/New-perspectives-for-bioenergyA “living pharmacy” crawls on the ocean floor off the coastline that stretches from Southern California to Mexico: biosyn Arzneimittel GmbH, a pharmaceutical company based in the city of Fellbach in southern Germany, produces a drug to treat bladder cancer, using the haemolymph, a vertebrate fluid equivalent to blood, of Megathura crenulata, commonly known as a giant keyhole limpet.
https://biopro-v9-test-gi.xanium.io/en/article/news/medicine-from-blue-blood-marine-snailsIn future, more lentils, soybeans, peas, field beans and lupins will be grown again in Baden-Württemberg farms. This is what Dr. Carola Blessing from the Agricultural Technology Center (LTZ) Augustenberg is working on. It therefore became clear very quickly that the LTZ Augustenberg needed to get involved in the "Rhizo-Linse" project that aims to further develop lentil cultivation.
https://biopro-v9-test-bio.xanium.io/en/articles/news/LTZ-Augustenberg-promotes-regional-protein-production
